Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Dostarlimab a miraculous cure for mismatch repair-deficient, locally advanced rectal cancer?
16 Jun 2022
Use of dostarlimab, a single-agent programmed death 1 (PD-1) monoclonal antibody, appears to have successfully cured mismatch repair-deficient, locally advanced rectal cancer, reports a recent study.
Dostarlimab a miraculous cure for mismatch repair-deficient, locally advanced rectal cancer?
16 Jun 2022
Concomitant insulin may counter renoprotective effects of SGLT2is in T2D patients with CKD
16 Jun 2022
Renal composite outcomes (RCO) appear to be less favourable among type 2 diabetes (T2D) patients with chronic kidney disease (CKD) treated with insulin and sodium-glucose cotransporter 2 inhibitors (SGLT2i), a recent Japan study has found.
Concomitant insulin may counter renoprotective effects of SGLT2is in T2D patients with CKD
16 Jun 2022
Fixed-dose albuterol/budesonide an effective rescue med in moderate-to-severe asthma
15 Jun 2022
bởiRoshini Claire Anthony
A fixed-dose combination of albuterol and budesonide, delivered as needed, reduced the risk of severe exacerbations in patients with moderate-to-severe asthma inadequately controlled with corticosteroid maintenance therapy, according to results of the phase III MANDALA trial presented at ATS 2022.
